Skip to content

Application of different doses of remimazolam tosylate in painless abortion: a randomized controlled trial.

Application of different doses of remimazolam tosylate in painless abortion

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000035255
Enrollment
Unknown
Registered
2020-08-05
Start date
2020-08-17
Completion date
Unknown
Last updated
2020-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless flow

Interventions

A:Remimazolam tosylate0.1mg/kg+ Sufentanil 0.15ug/kg
B:Remimazolam tosylate 0.15mg/kg+ Sufentanil 0.15ug/kg
C:Remimazolam tosylate 0.2mg/kg+ Sufentanil 0.15ug/kg

Sponsors

The First People's Hospital of Liangshan Yi Autonomous Prefecture
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-60 years, gender female; 2) Patients who receive routine painless abortion; 3) The ASA score is Grade I or Grade II; 4) 18kg/m2 < BMI < 30kg/m2; 5) The estimated operation time will not exceed 30 minutes.

Exclusion criteria

Exclusion criteria: 1) Patients who intend to undergo tracheal intubation; 2) Patients who are judged as having difficulty breathing management; 3) Anemia or thrombocytopenia, Hb = 2.5 * ULN, TBIL >= 1.5 * ULN; 5) Abnormal renal function, blood creatinine is greater than the upper limit of normal; 6) Hypertensive patients whose blood pressure has not been satisfactorily controlled by antihypertensive drugs (systolic blood pressure >= 160 mmHg, and/or diastolic blood pressure >= 100 mmHg); 7) Patients allergic to benzodiazepines and opioids; 8) Participated in other drug clinical trials as subjects in the past 3 months; 9) The investigator believes that it is inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
MOAA/S score;

Secondary

MeasureTime frame
Heart rate;blood pressure;breath rate;Blood oxygen saturation;

Countries

China

Contacts

Public ContactWangdiaoLan

The First People's Hospital of Liangshan Yi Autonomous Prefecture

764235804@qq.com+86 18989235988

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026